Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Sales of core domestic products and other items in the agricultural chemicals field remained firm, while overseas sales of the Danisaraba acaricide were strong. In the fertilizers and biostimulants field, sales of domestic fertilizers, the Atonik plant growth regulator overseas, and products sold by subsidiaries increased. However, the increase in inventories at a consolidated subsidiary limited their contribution to revenue and earnings.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥26,051 million (YoY +10.4%) |
| Operating profit | ¥3,447 million (YoY +13.4%) |
| Ordinary income | ¥3,207 million (YoY +6.6%) |
| Profit attributable to owners of the parent | ¥2,020 million (YoY +4.0%) |
| Net income per share | ¥200.05 |
| Equity ratio | End of the current fiscal period 49.8% / End of previous period 50.4% |
| Total assets | ¥40,424 million |
| Net assets | ¥21,215 million |
| Full-year earnings forecast | Net Sales ¥33,820 million (YoY +5.9%) / Operating profit ¥3,800 million (YoY +10.1%) / Ordinary income ¥3,700 million (YoY +3.3%) / Profit attributable to owners of the parent ¥2,410 million (YoY +3.5%) |
| Revision to Earnings Forecast | Whether revised No / Net Sales Not disclosed / Operating profit Not disclosed / Ordinary income Not disclosed / Profit attributable to owners of the parent Not disclosed |
| Annual Dividend Forecast | ¥60 → ¥60（0.0%） |
| Regional sales | Japan ¥7,152 million / Overseas ¥18,898 million |
| Depreciation and amortization | ¥955 million |
| Impairment loss | No expense recognized |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥0 million / Extraordinary loss Loss on disposal of fixed assets ¥2 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name Not disclosed |
| Material subsequent events | Not applicable |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 11,072,000 |
| Treasury Shares at Period-End | 965,483 |
| Factors Behind Changes in Business Performance | Sales of core domestic products and other items in the agricultural chemicals field remained firm, while overseas sales of the Danisaraba acaricide were strong. In the fertilizers and biostimulants field, sales of domestic fertilizers, the Atonik plant growth regulator overseas, and products sold by subsidiaries increased. However, the increase in inventories at a consolidated subsidiary limited their contribution to revenue and earnings. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales of the company's core domestic products in the agricultural chemicals field remained firm, while overseas sales of the Danisaraba acaricide were strong. In the fertilizers and biostimulants field, sales of domestic fertilizers, the Atonik plant growth regulator overseas, and products sold by subsidiaries increased. However, the increase in inventories at a consolidated subsidiary limited their contribution to revenue and earnings.